Aruna Biomedical Inc

Informações gerais

ArunA Biomedical is developing a new class of biologics targeting multiple
CNS disorders with an initial focus on treatments for patients with stroke,
traumatic brain and spinal cord injuries. In multiple preclinical studies
we have demonstrated that enhancing the nervous systems' self-repair
mechanisms translate into structural and functional benefits. Leveraging
our extensive experience producing neural-derived exosomes through a
proprietary, scalable manufacturing process we are advancing towards
multiple clinical programs.